Comparative Analysis of Clinical Profile, Laboratory Profile and Outcome in COVID-19 Patients with and Without Hypothyroidism

Overview

Journal Ghana Med J

Specialty General Medicine

Date 2024 Oct 14

PMID 39398090

Authors

B Sindhu Malini

Yoganathan Chidambaram

C P Clement Jenil Dhas

B K Navinkumar

S Sujith Kumar

Affiliations

Soon will be listed here.

Abstract

Objectives: Previous studies suggest that patients' thyroid status might directly impact the course of Coronavirus disease 2019 (COVID-19). The objective of the study was to determine the clinical profile of COVID-19 patients with hypothyroidism and compare it with that of COVID-19 patients without hypothyroidism.

Design: Retrospective observational study.

Setting: The study was conducted in a tertiary healthcare centre in Tamil Nadu between May and June 2021.

Participants: The study included 117 patients admitted with hypothyroidism and COVID-19 as well as 117 age and Gender matched COVID-19 patients without hypothyroidism.

Main Outcome Measures: Data regarding the demography, comorbidities, presenting symptoms, method of diagnosis of COVID-19, computed tomography (CT) severity score, Interleukin 6 (IL-6), D-dimer, oxygen requirement, number of days in hospital and outcome were collected for both groups. Data analysis was conducted, and p<0.05 was considered statistically significant.

Results: The study comprised 234 patients over two months, from May to June 2021. Distribution of presenting symptoms showed that the hypothyroidism group presented with a higher incidence of fever (66.67%), loose stool (18.80%) and myalgia (7.69%). Results show that RTPCR+, O Requirement, death, D-dimer, IL-6, number of days admitted as well as CT-severity did not show any statistically significant differences (p>0.05) between both groups. The outcomes also showed that both groups reported four mortalities.

Conclusions: The results of the study help conclude that the hypothyroidism status of a COVID-19 patient is not associated with higher severity of clinical symptoms, deranged laboratory values as well as mortality.

Funding: None declared.

References

Rossetti C, Cazarin J, Hecht F, de Lima Beltrao F, Freitas Ferreira A, Fortunato R . COVID-19 and thyroid function: What do we know so far?. Front Endocrinol (Lausanne). 2023; 13:1041676. PMC: 9806267. DOI: 10.3389/fendo.2022.1041676. View

Damara F, Muchamad G, Ikhsani R, Hendro , Syafiyah A, Bashari M . Thyroid disease and hypothyroidism are associated with poor COVID-19 outcomes: A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2021; 15(6):102312. PMC: 8530797. DOI: 10.1016/j.dsx.2021.102312. View

Fallahi P, Elia G, Ragusa F, Paparo S, Patrizio A, Balestri E . Thyroid Autoimmunity and SARS-CoV-2 Infection. J Clin Med. 2023; 12(19). PMC: 10573843. DOI: 10.3390/jcm12196365. View

Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P . Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2020; 22(4):803-815. PMC: 7688298. DOI: 10.1007/s11154-020-09615-z. View

Piekarska A, Goral M, Kozula M, Jawiarczyk-Przybylowska A, Zawadzka K, Bolanowski M . The Influence of SARS-CoV-2 Infection on the Thyroid Gland. Biomedicines. 2023; 11(2). PMC: 9953074. DOI: 10.3390/biomedicines11020614. View

Daraei M, Hasibi M, Abdollahi H, Hazaveh M, Zebaradst J, Hajinoori M . Possible role of hypothyroidism in the prognosis of COVID-19. Intern Med J. 2020; 50(11):1410-1412. PMC: 7753499. DOI: 10.1111/imj.15000. View

Lui D, Lee C, Chow W, Lee A, Tam A, Fong C . Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19. J Clin Endocrinol Metab. 2020; 106(2):e926-e935. PMC: 7665541. DOI: 10.1210/clinem/dgaa813. View

Przezak A, Bielka W, Pawlik A . Hypertension and Type 2 Diabetes-The Novel Treatment Possibilities. Int J Mol Sci. 2022; 23(12). PMC: 9224227. DOI: 10.3390/ijms23126500. View

Bakshi S, Kalidoss V . Is there an association between hypothyroidism and COVID 19? : A preliminary report. Wien Klin Wochenschr. 2021; 133(7-8):414-415. PMC: 7857644. DOI: 10.1007/s00508-021-01813-2. View

10.

Carle A, Bulow Pedersen I, Knudsen N, Perrild H, Ovesen L, Laurberg P . Gender differences in symptoms of hypothyroidism: a population-based DanThyr study. Clin Endocrinol (Oxf). 2015; 83(5):717-25. DOI: 10.1111/cen.12787. View

11.

Bagala V, Sala A, Trevisan C, Okoye C, Incalzi R, Monzani F . Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study. J Endocrinol Invest. 2023; 46(9):1891-1899. PMC: 10040305. DOI: 10.1007/s40618-023-02048-w. View

12.

Bogojevic M, Bansal V, Pattan V, Singh R, Tekin A, Sharma M . Association of hypothyroidism with outcomes in hospitalized adults with COVID-19: Results from the International SCCM Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry. Clin Endocrinol (Oxf). 2022; 101(1):85-93. PMC: 9111656. DOI: 10.1111/cen.14699. View

13.

Lania A, Sandri M, Cellini M, Mirani M, Lavezzi E, Mazziotti G . Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020; 183(4):381-387. PMC: 9494315. DOI: 10.1530/EJE-20-0335. View

14.

Jin J, Bai P, He W, Wu F, Liu X, Han D . Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020; 8:152. PMC: 7201103. DOI: 10.3389/fpubh.2020.00152. View

15.

Muller-Wieland D, Marx N, Dreher M, Fritzen K, Schnell O . COVID-19 and Cardiovascular Comorbidities. Exp Clin Endocrinol Diabetes. 2020; 130(3):178-189. DOI: 10.1055/a-1269-1405. View

16.

Pandey S, Sharma V . World diabetes day 2018: Battling the Emerging Epidemic of Diabetic Retinopathy. Indian J Ophthalmol. 2018; 66(11):1652-1653. PMC: 6213704. DOI: 10.4103/ijo.IJO_1681_18. View

17.

Cabuk S, Cevher A, Kucukardali Y . Thyroid Function During and After COVID-19 Infection: A Review. touchREV Endocrinol. 2022; 18(1):58-62. PMC: 9354510. DOI: 10.17925/EE.2022.18.1.58. View

18.

Muller I, Cannavaro D, Dazzi D, Covelli D, Mantovani G, Muscatello A . SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020; 8(9):739-741. PMC: 7392564. DOI: 10.1016/S2213-8587(20)30266-7. View

19.

Tee L, Harjanto S, Rosario B . COVID-19 complicated by Hashimoto's thyroiditis. Singapore Med J. 2020; 62(5):265. PMC: 8801861. DOI: 10.11622/smedj.2020106. View

20.

Burekovic A, Halilovic D, Sahbaz A . Hypothyroidism and Subclinical Hypothyroidism as a Consequence of COVID-19 Infection. Med Arch. 2022; 76(1):12-16. PMC: 8976890. DOI: 10.5455/medarh.2022.76.12-16. View